IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 12 holdings | $45.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$42.5M180,00093.5%
Avanos Medical Inc(AVNS)COM05350V106$2.6M62,0575.8%
United Therapeutics Corp(UTHR)COM91307C102$59.3K505,2990.1%
Mckesson Corp(MCK)COM58155Q103$48.2K411,6550.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$45.5K476,0420.1%
Amgen Inc(AMGN)COM031162100$36.8K193,6700.1%
Gilead Sciences Inc(GILD)COM375558103$36.3K558,8270.1%
Merck & Co. Inc(MRK)COM58933Y105$34.3K412,8090.1%
Elanco Animal Health Inc(ELAN)COM28414H103$29.0K904,2020.1%
RTI Surgical HDS IncCOM74975N105$23.9K3,971,9970.1%
Invacare CorpCOM461203101$11.3K1,349,7410.0%
Digirad CorpCOM253827109$269295,1680.0%